Phase 2 Hepatic Metastasis Clinical Trials

3 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–3 of 3 trials

Recruiting

Phase 2

Hepatic Arterial Infusion of Sodium Bicarbonate (NaHCO3) Combined With NASOX Regimen and Programmed Death-1 (PD-1) Inhibitors for Pancreatic Cancer Liver Metastases

Pancreatic NeoplasmsHepatic Metastasis of Pancreatic Cancer

Ruijin Hospital50 enrolled1 locationNCT07504471

Recruiting

Phase 2

Magnetic Resonance-guided Adaptive Stereotactic Body Radiotherapy for Hepatic Metastases

Hepatic Metastasis

University Hospital Heidelberg90 enrolled1 locationNCT05027711

Recruiting

Phase 2

Oxaliplatin Combined With Irinotecan Liposome Injection II Through Hepatic Artery Infusion (HAIC) Followed by 5-FU/LV (HAIC) or Tegorgor Oral Combination Therapy for Hepatic Metastasis of Pancreatic Cancer

Neoplasm MetastasisPancreatic NeoplasmsHepatic Metastasis of Pancreatic Cancer

Ruijin Hospital40 enrolled1 locationNCT06538623